RecruitingNot Applicable

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

Italy126 participantsStarted 2021-01-01

Plain-language summary

The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with specific prescription to initiate therapy with antiresorptive drugs Exclusion Criteria: * Previous Head and Neck Radiotherapy

What they're measuring

Medication Related OsteoNecrosis of the Jaws

Timeframe: Five years after the beginning of AR therapy

Trial details

NCT IDNCT06457776

SponsorCatholic University of the Sacred Heart

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-01

Contact for this trial

Carlo Lajolo, Prof.

3356078354 carlo.lajolo@unicatt.it

View on ClinicalTrials.gov More Osteonecrosis of the Jaw trials